Omeros Corporation Banner Image

Omeros Corporation

  • Ticker OMER
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Omeros Corporation Logo Image
  • 51-200 Employees
  • Based in Seattle, Washington
Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets Omidria for use during cataract surgery or intraocular lens, or replacement surgery.
Omeros Corporation

Most Recent Annual Report

Omeros Corporation MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Omeros Corporation has reached its limit for free report views.

Older/Archived Annual Reports